Document is current
Any future updates will be listed below
-
Authors
Micheletti, J. Morgan https://orcid.org/0000-0002-3657-5573
Shultz, Mitchell
Singh, Inder Paul
Samuelson, Thomas W.
- License Information
-
More Information
Article History
Received: 10 October 2024
Accepted: 4 November 2024
First Online: 30 November 2024
Declarations
:
: J. Morgan Micheletti: Alcon (consultant, researcher, speaker); Allergan (AbbVie)(consultant, researcher); Avellino (consultant); Bausch & Lomb (consultant), BVI (consultant); Centricity Vision (consultant); Diamatrix (consultant, patent); Elios (consultant); Glaukos Corp. (consultant, speaker); Johnson and Johnson Vision (consultant, researcher); Lenstec (consultant, researcher, speaker); New World Medical (consultant, speaker); RxSight (consultant); Samsara (consultant); STAAR (consultant, researcher, speaker); Tarsus (consultant); Visus Therapeutics (consultant); Zeiss (consultant, speaker). Mitchell Shultz: Alchemy Vision (Co-Founder, Investor, Speaker); Allergan/AbbVie (Consultant, Speaker); Aerie/Alcon Pharmaceuticals (Consultant, Researcher); Bausch + Lomb (Consultant, Researcher, Speaker); BVI (Consultant, Researcher); Cloudbreak (Consultant, Researcher, Speaker); Glaukos (Consultant, Researcher, Speaker); Glint Pharma (Consultant, Medical Advisory Board); Harrow (Consultant, Speaker); HDMD (Consultant); Johnson & Johnson (Consultant, Researcher); LENSAR (Consultant); New World Medical (Consultant, Researcher); Ocuphire (Consultant, Researcher); RegenTree (Consultant, Researcher); RxSight (Consultant, Researcher, Speaker); Sanoculis (Consultant, Researcher, Speaker); Scope Pharm (Consultant); Sight Science (Consultant, Speaker); SUN Pharm (Consultant, Speaker); Tarsus (Consultant, Researcher, Speaker); Tracey Technologies (Consultant, Speaker); Trukera (Consultant); Twenty Twenty (Consultant); Zeiss (Consultant, Researcher. Speaker). Inder Paul Singh: speaker and consultant for Glaukos, Allergan, New World Medical, Ivantis, Sight Sciences, Ocular Therapeutix, Sun Pharmaceuticals, Novartis, Bausch + Lomb, Kala Pharmaceuticals, and EyePoint Pharmaceuticals. Thomas W. Samuelson: consultant for Aerie Pharmaceuticals, Alcon Surgical, Allergan, Bausch & Lomb/Valeant, BELKIN Vision, ELT Sight, Equinox, Glaukos, Imprimis, Irisvision, Ivantis, Johnson & Johnson Vision, Ocuphire, MicroOptx, New World Medical, PolyActiva, Ripple Therapeutics, Santen, Sight Science, TearClear, Vialase, and Zeiss Meditec; and stock options from Belkin Vision, Equinox, Ivantis, Ocuphire, Sight Science, Tear Clear, and Vialase.
: This article is based on previously conducted studies and does not contain any new studies with human participants or animals performed by any of the authors.
